BelataceptOpportunistic infections: 34 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1800卷 / 1期

关键词：

D O I：

10.1007/s40278-020-77438-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：76 / 76

相关论文

共 50 条

[21] MelphalanHaematotoxicity and infections: 4 case reports
Reactions Weekly, 2019, 1773 (1) : 220 - 220
[22] ImmunosuppressantsCytomegalovirus infections: 13 case reports
Reactions Weekly, 2018, 1717 (1) : 161 - 161
[23] DaratumumabVarious infections: 9 case reports
Reactions Weekly, 2019, 1749 (1) : 160 - 160
[24] RituximabViral infections: 4 case reports
Reactions Weekly, 2002, 902 (1) : 10 - 10
[25] Acetylleucine/tozinameranVarious toxicities: 34 case reports
Reactions Weekly, 2025, 2048 (1) : 18 - 18
[26] AntineoplasticsMyelosuppression and infections: 2 case reports
Reactions Weekly, 2022, 1913 (1) : 67 - 67
[27] ImmunosuppressantsFatal infections: 3 case reports
Reactions Weekly, 2018, 1701 (1) : 156 - 156
[28] ImmunosuppressantsNeisseria infections: 7 case reports
Reactions Weekly, 2019, 1742 (1) : 121 - 121
[29] AntineoplasticsVarious infections: 10 case reports
Reactions Weekly, 2023, 1981 (1) : 46 - 46
[30] AlemtuzumabMycobacterial infections: 7 case reports
Reactions Weekly, 2008, 1201 (1) : 5 - 5

← 1 2 3 4 5 →